Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. McCarron
Comparison of Dabigatran Etexilate Versus Warfarin, Asprin & No Treatment for Stroke Prevention in Atrial Fibrillation in England, United Kingdom, Over 5 Years
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Treatments for Stroke Prevention in Atrial Fibrillation: A Network Meta-Analysis and Indirect Comparisons Versus Dabigatran Etexilate
Thrombosis and Haemostasis
Hematology
PCV59 Cost-Effectiveness of Dabigatran Etexilate Versus Apirin Plus Clopidogrel Combination in Stroke Prevention in Atrial Fibrillation (SPAF): Russian Payer Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PCV56 Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation Under the Private and Public Health Care System in Brazil
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Dabigatran Challenges Warfarin's Superiority for Stroke Prevention in Atrial Fibrillation
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Warfarin Versus Warfarin and Aspirin in Atrial Fibrillation
Neurological Bulletin
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Stroke Prevention in Atrial Fibrillation
Journal of Atrial Fibrillation
Cardiovascular Medicine
Cardiology
Stroke Prevention in Atrial Fibrillation
International Journal of Arrhythmia
